Intensive Care Department, Salengro Hospital,CHRU
Lille, France
NCT Number: NCT03066375
Objectives: To investigate whether respiratory variations of inferior vena cava diameters (cIVC) predict fluid responsiveness in spontaneously breathing patients with septic acute circulatory failure and irregular heartbeats.
Design: Prospective, bicentric study, intensive care units.
Patients and measures: Spontaneously breathing patients with sepsis and clinical signs of acute circulatory failure are included. A positive response to fluid loading (FL) is defined as an increase of the stroke volume (SV) >10%. The investigators measured the minimum inspiratory and maximum expiratory diameters of the IVC (idIVC and edIVC) during standardized (st) and unstandardized (ns) breathing. The investigators calculated cIVCst and cIVCns before a 500ml-colloid FL.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Lille, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasonographic recordings are recorded immediately before and after volume expansion (VE), performed as a 30-minute infusion of 500 mL of 4% gelatin. Inferior Vena Cava diameters are measured during spontaneous and standardized respiratory cycles. Stroke volume is measured during spontaneous respiratory cycles.
Time frame: during 30 minutes of the volume expansion
University Hospital, Lille
Other
Diagnostic Accuracy of the Inferior Vena Cava Collapsibility to Predict Fluid Responsiveness in Spontaneously Breathing Patients With Sepsis, Acute Circulatory Failure, and Irregular Cardiac Rhythm
Acronym: ReVaPreF2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03066362
Circulatory Failure, Infections
Lille, Hauts-de-France, France
View Trial DetailsNCT07242027
Cardiac Arrest, Cardiovascular Diseases
Zabrze, Silesian Voivodeship, Poland
View Trial DetailsNCT03788772
Acute Circulatory Failure, Infections
Paris, France
View Trial DetailsNCT06181604
Infections, Inflammation
Boston, Massachusetts, United States
View Trial Details